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ABSTRACT
Objective: This study aimed to compare pelvic inflammatory disease (PID) symptoms in curettage procedure with three antibiotic prophylaxis 
strategies.
Methods: The patients were allocated to three Groups (A, B, and C). Group A was patients receiving prophylactic antibiotics and post-curettage 
antibiotics, Group B received prophylactic antibiotics without post-curettage antibiotics, and Group C did not receive prophylactic antibiotics 
but received post-curettage antibiotics. The outcomes measured to identify the occurrence of PID symptoms included leukocytes, erythrocyte 
sedimentation rate, temperature, pain, vaginal discharge, and bleeding.
Results: This study shows that there were no significant differences in any PID symptoms between antibiotic strategies except for pain scale (p=0.03).
Conclusion: The PID symptoms between the three strategies of antibiotic prophylaxis were similar.
Keywords: Antibiotic prophylaxis, Curettage, Obstetrics and gynecology department, Pelvic inflammatory disease.
INTRODUCTION
The antibiotic discovery is confine [1], but there is an abundant 
use of antibiotics not only occur at community [2] but also at the 
hospital [3,4]. The perspective database (Premier Inc., Charlotte, NC), a 
voluntary database that captures data from >500 acute-care hospitals 
from throughout the United States, was used to analyze antibiotic use 
in women who underwent inpatient or outpatient gynecologic surgery 
between 2003 and the first quarter of 2010. The database analysis result 
shows that antibiotics are increasingly being administered to women 
who underwent gynecologic surgery from 88.0% in 2003 to 90.7% in 
2010 (p<0.001). Among 491,071, who underwent operations for which 
antibiotics were not recommended, antibiotics were administered to 
197,226 (40.2%); among 545,332 women who underwent procedures 
for which antibiotics were recommended, 87.1% received appropriate 
antibiotic prophylaxis, 2.3% received nonguideline-recommended 
antibiotics, and 10.6% received no prophylaxis [5].
Prophylactic antibiotics aim to prevent the incidence of surgical wound 
infections, reduce the incidence of post-operative morbidity and 
mortality, inhibit the emergence of normal resistant flora, and reduce 
the cost of treatment. In general, prophylactic antibiotics in the surgical 
procedure are not used to sterilize tissues but to suppress the presence 
of microorganisms until the patient’s immune system can resist the 
microorganisms present during the surgical procedure [6,7].
The selection of antibiotics used in hospitals is based on the policy 
or guidelines on the use of antibiotics, diagnostic and therapeutic 
guidelines, as well as the hospital formulary. Therefore, each hospital has 
a different policy with regard to the use of antibiotics, since the principle 
of antibiotic selection is based on the conditions in each hospital, 
including the fitness of antibiotics with local bacterial sensitivity in the 
hospital, as well as the cost-effectiveness of the antibiotics used. The 
benefit of the administration of prophylactic antibiotics for curettage 
procedure remains unclear and controversial. Some studies suggest 
that antibiotic prophylaxis in curettage is ineffective while others found 
that antibiotic prophylaxis in curettage is effective in reducing the 
occurrence of infection.
An infection that can potentially occur in curettage is a pelvic 
inflammatory disease (PID), an infection of the upper female 
reproductive system that is related to endometritis, salpingitis, and 
pelvic peritonitis. PID can lead to more serious reproductive disabilities, 
including infertility, ectopic pregnancy, and chronic pelvic pain [8-10].
Research evidence on the effectiveness of prophylactic antibiotics on 
curettage has been limited and controversial [6,7,9]. The justification 
to use antibiotic is because the curettage procedure performs 
transvaginally, and the patients had a risk of infection by pathogens in 
the lower genital tract [11]. One research which supports not giving 
antibiotic prophylactics for the curettage procedure is a prospective 
study by Al-Ghoweri et al. conducted at King Hussein Medical Center, 
in Amman, Jordan, showing that the PID incidence was 9.5% in 
Group I (prophylactic antibiotics were administered) and 10.14% 
in Group II (prophylactic antibiotics were not administered), for 
which this difference was not statistically significant [12]. Whereas, 
research which shows the benefit of antibiotic prophylaxis in curettage 
procedure includes a study which found a significant reduction in post-
operative PID in low-risk patients, who were applying for legal first-
trimester abortion and treated pre-operatively with ceftriaxone [13]. 
In a systematic review, the author concludes that antibiotic prophylaxis 
may be beneficial in the first-trimester suction curettage [14].
This research aimed to compare the incidence of PID between several 
regimens of antibiotic administered in patients with curettage procedure.
METHODS
The study was conducted at a private secondary care hospital with 50 
beds, PKU Muhammadiyah Hospital, Jalan K.H.M Mansyur 180–182, 
in Surabaya, Indonesia. From May 2015 to July 2016, there were 60 
subjects who met study criteria and were classified into three groups: 
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(i) Group A was a group of patients who received 1 × 2 g of prophylactic 
antibiotic cefazolin injection and 3 × 500 mg of post-antibiotic 
amoxicillin, (ii) Group B was a group of patients who received 1 × 2 g of 
prophylactic antibiotic cefazolin injection without post-antibiotics, and 
(iii) Group C was a group of patients who did not receive prophylactic 
antibiotics but received 3 × 500 mg of post-antibiotic amoxicillin. After 
5-days follow-up, PID symptoms were identified by observation of the 
occurrence of leukocyte >10,500 mm3, erythrocyte sedimentation rate 
(ESR) >15 mm/L, lower abdominal pain, temperature >38°C, changes 
in vaginal fluid characteristics including odor and consistency in 
vaginal discharge, and bleeding outside the menstrual cycle (irregular 
bleeding). The pain levels were measured with a numerical pain rating 
scale (NPRS). NPRS is a pain measurement in the form of a straight 
line scale consisting of number scores of 0–10: 1–3 is a mild pain, 4–7 
is a moderate pain, and 8–10 is a severe pain. Vaginal discharge and 
bleeding were categorized as 1 - none, 2 - a few, and 3 - approximately 
twice less from number 2.
One-way ANOVA or non-parametric Kruskal–Wallis tests were used to 
analyze the data’s distribution and significance statistically.
RESULTS AND DISCUSSION
Curettage is the most common services done in PKU Muhammadiyah 
Hospital, and on average, there are 15 patients per month with various 
indications, either based on diagnostic indications, such as irregular 
menstrual bleeding, severe menstrual bleeding, and postmenopausal 
bleeding, or therapeutic indications, such as endometrial hyperplasia, 
endometrial polyps, stem submucosal myomas, residual conception 
products after abortion, and failed abortions. PKU Muhammadiyah 
Hospital does not have any antibiotic guidelines for the curettage 
procedure, even though antibiotics are always given to the patient. 
This study showed that the patients’ characteristics were similar. The 
average age was 32 years in Group A, 30 years in Group B, and 35 years 
in Group C. There were several patient curettage indications (Table 1). 
The common curettage indication was abortion: 65% in Group A, 65% 
in Group B, and 70% in Group C. The rate of abortion indication in 
this hospital is similar to other health facilities in Indonesia. A study 
conducted in the year 2000 from some health facilities in six regions in 
Indonesia showed that approximately two million abortions were done 
in Indonesia, including an unknown number of spontaneous abortions, 
which was underestimated [15]. The annual abortion rate is 37 in 
every 1000 women with reproductive ages of 15–49 years. The study 
also reported that 760,000 (17%) of the 4.5 million annual births were 
unwanted or unplanned. The situation in Indonesia is high compared 
to other Asian countries, with 29 abortions in every 1000 women [16].
The occurrence of the PID symptoms between groups was similar, except 
pain (Table 2). The mean NPRS Group A was 1.5 (group A), Group B was 
1.75, and Group C was 1.05 (p=0.03). The mean NPRS between Groups A 
and B was 0.45, indicating a difference of 0.45 with an increasing 
tendency in Group A (since the value was positive). The mean NPRS 
between Groups A and B was −0.25, indicating a difference of 0.25 with an 
increasing tendency in Group B (since the value was negative). The NPRS 
mean difference between Groups A and B was 0.7, indicating a difference of 
0.7 with an increasing tendency in Group B (since the value was positive). 
Unlike a study at Bengaluru [17], this study shows that there are no 
significant differences in any PID symptom except pain between antibiotic 
strategies. This result confirms a previous study which showed that there 
was no significant difference found between high-risk patients treated 
with ceftriaxone or ampicillin/pivampicillin and metronidazole [13]. In 
addition, a systematic review concluded that the antibiotic prophylaxis 
effectiveness is similar between several antibiotic regimens [18].
Although rare, it is possible to develop multivalvular, right-sided, 
and left-sided endocarditis [19,20] or endogenous candida 
endophthalmitis [21]. Consideration to give antibiotic prophylaxis is 
for the patient which have the endocarditis or endophthalmitis risk. 
In general, the antibiotic is not effective to prevent PID after curettage 
[22,23]. A study in 67 women, 1 month after an endometrial curettage, 
PID occurs in four women from intervention group who received 
doxycycline 200 mg daily for 1 week after the procedure and three 
women from the control group who did not receive any antibiotic 
regimen (p>0.05) [24]. Another study with 84 women with uterine 
curettage showed that only two cases of endometritis were found in 
the group who were given 0.1 ml of Vitamin B complex intravenously 
20 minutes before curettage but none in the group who 1 g of cefoxitin 
intravenously 20 minutes before curettage (p=0.241) [25].








17–22 4 (20) 8 (40) 5 (25)
23–28 10 (50) 4 (20) 7 (35)
29–34 4 (20) 5 (25) 3 (15)
35–40 1 (5) 2 (10) 3 (15)
41–46 1 (5) 1 (5) 1 (5)
47–52 0 (0) 0 (0) 1 (5)
Indication
Abortus incomplete 13 (65) 13 (65) 14 (70)
Dead conceptus 3 (15) 1 (5) 2 (10)
Blighted ovum 3 (15) 4 (20) 2 (10)
Fluxus pervaginam 1 (5) 2 (10) 1 (5)




>10,500 mm3 1 2 0
Erythrocyte sedimentation rate
>15 mm/l 5 10 14
Abdominal pain (NPRS 1–10)
1–3 19 (95) 20 (100) 18 (90)
4–7 1 (5) 0 (0) 2 (10)
8–10 0 (0) 0 (0) 0 (0)
Temperature
>38°C 0 0 0
Vaginal discharge
1 19 (95) 20 (100) 17 (85)
2 1 (5) 0 (0) 3 (15)
3 0 (0) 0 (0) 0 (0)
Bleeding
1 4 (20) 5 (25) 7 (35)
2 11 (55) 9 (45) 11 (55)
3 5 (25) 6 (30) 2 (10)
Table 2: Pelvic inflammatory disease symptoms after 5‑day 
follow‑up
Characteristics Group A (%) Group B (%) Group C (%)
Leukocyte
>10,500 mm3 2 (10) 0 (0) 0 (0)
Erythrocyte 
sedimentation rate
>15 mm/l 7 (35) 11 (55) 14 (70)
Abdominal 
pain (NPRS 1–10)
1–3 12 (60) 9 (45) 19 (95)
4–7 6 (30) 7 (35) 1 (5)
8–10 2 (10) 4 (20) 0 (0)
Temperature
>38°C 0 (0) 0 (0) 0 (0)
Vaginal discharge
1 20 (100) 17 (85) 19 (95)
2 0 (0) 3 (15) 1 (5)
3 0 (0) 0 (0)
Bleeding
1 13 (65) 4 (20) 9 (45)
2 7 (35) 10 (80) 9 (45)
3 0 (0) 0 (0) 2 (10)
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CONCLUSION
There was no significant difference except pain in the occurrence of 
PID’s symptoms after curettage procedure and there was no difference 
in improvement of symptoms between the three strategies of antibiotic 
prophylaxis, pre- and post-curettage procedure.
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